While many of
the 180,000 American men likely to be diagnosed with prostate cancer this year
will find their condition is low risk, that is simply not always the case. Some
men will find their diagnosis relates to a more aggressive, higher risk form of
the disease. New research, however, is showing that a combination treatment may
offer some of those in the higher risk category a greater chance for successful
treatment with a significantly higher five-year disease-free survival rate.
